Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes
Open Access
- 1 January 2015
- journal article
- review article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 21 (38), 10811-23
- https://doi.org/10.3748/wjg.v21.i38.10811
Abstract
Hepatitis C virus (HCV) genotypes’ monitoring allows real-time insight into the dynamic changes that occur in the global epidemiological picture of HCV infection. Intravenous drug use is currently the primary driver for HCV transmission in developed and developing countries. The distribution of HCV genotypes/subtypes differs significantly between people who inject drugs (PWID) and the general population. HCV genotypes that previously exhibited a limited geographical distribution (3a, 4) are becoming more prevalent in this high-risk group. Immigration from HCV-endemic countries and the evolving networks of HCV transmission in PWID influence HCV genotypes distribution in Europe. Social vulnerabilities (e.g., unemployment, homelessness, and limited access to social and healthcare insurances systems) are important triggers for illicit drug use, which increases the associated risks of HCV infection and the frequent emergence of less prevalent genotypes. Genotype/subtype determination bears important clinical consequences in the progression of liver disease, susceptibility to antiviral therapies and the emergence of resistance-associated variants. An estimated half of the chronically HCV-infected PWID are unaware of their infection, and only one in ten of those diagnosed enter treatment. Nevertheless, PWID exhibit high response rates to new antiviral regimens, and the level of HCV reinfection is unexpectedly low. The focus of the healthcare system must be on the early detection and treatment of infection, to avoid late presentations that are associated with high levels of viremia and liver fibrosis, which may diminish the therapeutic success rate.Keywords
This publication has 118 references indexed in Scilit:
- The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesisBMC Infectious Diseases, 2013
- Identification of Rodent Homologs of Hepatitis C Virus and PegivirusesmBio, 2013
- Bats are a major natural reservoir for hepaciviruses and pegivirusesProceedings of the National Academy of Sciences of the United States of America, 2013
- Epidemiological features and specificities of HCV infection: a hospital-based cohort study in a university medical center of Calabria regionBMC Infectious Diseases, 2012
- Injection behaviors among injection drug users in treatment: The role of hepatitis C awarenessAddictive Behaviors, 2012
- Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infectionJournal of Hepatology, 2011
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsThe Lancet, 2011
- Emergence of Hepatitis C Virus Genotype 4: Phylogenetic Analysis Reveals Three Distinct Epidemiological ProfilesJournal of Clinical Microbiology, 2009
- Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infectionAddiction, 2009
- Use of Sequence Analysis of the NS5B Region for Routine Genotyping of Hepatitis C Virus with Reference to C/E1 and 5′ Untranslated Region SequencesJournal of Clinical Microbiology, 2007